Koichi Ito Selected Research

Lymph Node Excision (Lymph Node Dissection)

1/2019	The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma.
6/2018	[Fetal Adenocarcinoma of the Lung].
1/2012	Serum intact parathyroid hormone level after total thyroidectomy or total thyroidectomy plus lymph node dissection for thyroid nodules: report from 296 surgical cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Ito Research Topics

Disease

44	Neoplasms (Cancer) 12/2024 - 09/2003
34	Thyroid Neoplasms (Thyroid Cancer) 01/2024 - 09/2003
33	Graves Disease (Basedow Disease) 05/2024 - 06/2004
20	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2003
14	Hyperthyroidism 10/2022 - 06/2004
13	Inflammation (Inflammations) 03/2024 - 12/2003
9	Thyroid Diseases (Thyroid Disease) 01/2022 - 11/2002
8	Follicular Adenocarcinoma 11/2023 - 07/2011
8	Periodontal Diseases (Periodontal Disease) 01/2013 - 02/2002
7	Thyrotoxicosis 01/2024 - 10/2005
7	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2010
7	Infections 01/2023 - 01/2006
6	Anaplastic Thyroid Carcinoma 01/2023 - 08/2007
6	Disease Progression 10/2022 - 10/2009
6	Papillary Thyroid Cancer 08/2020 - 08/2007
6	Periodontitis 06/2012 - 12/2002
5	Hypothyroidism 01/2024 - 12/2006
5	Thyroid Nodule (Nodule, Thyroid) 01/2023 - 12/2011
4	Agranulocytosis (Granulocytopenia) 05/2024 - 01/2012
4	Hypertension (High Blood Pressure) 11/2023 - 11/2018
4	Goiter 01/2023 - 06/2004
4	Cholestasis 05/2022 - 04/2016
4	Proteinuria 08/2021 - 01/2019
4	Carcinoma (Carcinomatosis) 07/2021 - 09/2003
4	Thyroiditis 04/2018 - 01/2004
4	Graves Ophthalmopathy 01/2018 - 01/2015
4	Lymphatic Metastasis 12/2016 - 03/2003
3	Triple Negative Breast Neoplasms 03/2024 - 01/2016
3	Pathologic Constriction (Stenosis) 05/2021 - 09/2008
3	progressive familial intrahepatic 1 Cholestasis 01/2021 - 04/2016
3	Hypocalcemia 02/2019 - 12/2008
3	Hemorrhage 08/2017 - 01/2007
3	Osteosarcoma (Osteogenic Sarcoma) 02/2007 - 09/2004
2	Hepatitis 04/2024 - 01/2006
2	Necrosis 12/2023 - 12/2012
2	Dyspepsia (Indigestion) 10/2023 - 08/2022
2	Chronic Hepatitis C 01/2023 - 05/2011
2	Adenocarcinoma 10/2022 - 06/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 06/2021
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2021 - 08/2009
2	Hearing Loss (Hearing Impairment) 02/2021 - 01/2020
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2021 - 03/2011
2	Intrahepatic Cholestasis 01/2021 - 04/2016
2	Liver Diseases (Liver Disease) 01/2021 - 06/2016

Drug/Important Bio-Agent (IBA)

15	lenvatinibIBA 11/2023 - 01/2014
13	Antithyroid Agents (Antithyroid Drugs)IBA 05/2024 - 06/2004
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2006
11	IodineIBA 07/2021 - 12/2006
9	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2024 - 11/2002
9	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2024 - 10/2005
8	Methimazole (Thiamazole)FDA LinkGeneric 05/2024 - 12/2006
8	RacivirIBA 11/2023 - 07/2011
8	thyrotropin-binding inhibitory immunoglobulinIBA 01/2023 - 01/2004
8	Tyrosine Kinase InhibitorsIBA 11/2022 - 08/2017
7	Propylthiouracil FDA Link 05/2024 - 12/2006
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2012
7	AntibodiesIBA 01/2021 - 06/2007
6	Thyroid HormonesIBA 05/2024 - 12/2006
5	Thyroglobulin FDA Link 01/2023 - 12/2006
4	EnzymesIBA 10/2023 - 01/2021
4	Potassium Iodide (Pima)FDA Link 05/2023 - 10/2015
4	Parathyroid Hormone (Parathormone)IBA 07/2022 - 12/2008
4	Galectin 1 (LGALS1)IBA 12/2012 - 12/2010
4	CytokinesIBA 12/2012 - 05/2006
3	IronIBA 02/2024 - 10/2015
3	VaccinesIBA 02/2024 - 07/2013
3	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 10/2009
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2023 - 06/2015
3	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2023 - 10/2005
3	Long-Acting Thyroid Stimulator (LATS)IBA 10/2022 - 01/2011
3	CalciumIBA 07/2022 - 12/2008
3	Carrier Proteins (Binding Protein)IBA 06/2021 - 08/2012
3	AntigensIBA 06/2021 - 01/2004
3	Thyrotropin Receptors (Thyrotropin Receptor)IBA 06/2021 - 11/2008
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2021 - 08/2009
3	Troleandomycin (TAO)FDA Link 01/2018 - 01/2011
2	Dihydrotachysterol (AT 10)IBA 05/2024 - 08/2011
2	Hormones (Hormone)IBA 05/2024 - 04/2018
2	NAD (NADH)IBA 12/2022 - 01/2019
2	Phenobarbital (Luminal)FDA Link 08/2022 - 01/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2022 - 01/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 11/2007
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2006
2	AutoantibodiesIBA 01/2021 - 11/2008
2	Amino Acids FDA Link 12/2020 - 10/2013
2	Arginine (L-Arginine)FDA Link 12/2020 - 01/2007
2	Triglycerides (Triacylglycerol)IBA 12/2020 - 11/2018
2	Desflurane (I 653)FDA Link 01/2020 - 01/2017

Therapy/Procedure

48	Therapeutics 04/2024 - 06/2004
21	Thyroidectomy 11/2023 - 06/2004
10	Drug Therapy (Chemotherapy) 03/2024 - 09/2009
6	Radiotherapy 02/2023 - 01/2011
5	Stents 12/2023 - 09/2008
4	Aftercare (After-Treatment) 08/2021 - 12/2002
3	Glycemic Control 01/2021 - 05/2010
3	Operative Surgical Procedures 02/2019 - 01/2012
3	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 01/2012
3	Palliative Care (Palliative Therapy) 11/2018 - 11/2013
3	Immunotherapy 01/2011 - 01/2007